Insights from a Global Program Leader in the Pharmaceutical Industry

Kenneth Maynard is a senior director in global patient safety and evaluation at Takeda Pharmaceuticals, Inc., where he’s held several roles. He began there in 2014 as a global program leader in the central nervous system therapeutic area unit. Previously, Maynard worked at Sanofi, a top five global pharmaceutical company in central nervous system research and development and external innovation. Formerly, he was an assistant professor in neurosurgery at Massachusetts General Hospital and Harvard Medical School. With more than 50 scientific publications, Maynard has served as a reviewer for several peer-reviewed, international journals. He is a fellow of the American Heart Association, Councilor of the Society for Neuroscience, and serves on the advisory boards of Worcester Polytechnic Institute's College of Arts & Sciences, and the National Institute of Nervous Disorders and Stroke. He previously served on the National Institute of Mental Health Neuropsychopharmacology Taskforce, Executive Committee of the International Dose-Response Society, the NIH Director’s Program on Broadening Experiences in Scientific Training and the National Academies of Sciences Committee on the Next Generation of Biomedical and Behavioral Sciences Researchers. He completed his undergraduate, master’s, and doctorate degrees from the University of London, University College.